Status:
COMPLETED
PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.
Lead Sponsor:
Boehringer Ingelheim
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this trial is to evaluate the safety and virological and immunological efficacy of Viramune® on a background of different antiretroviral drug combinations.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- The inclusion criteria follow the same criteria which are describe in the newest SPC.
- Exclusion criteria:
- The exclusion criteria follow the same criteria which are describe in the newest SPC.
Exclusion
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT00736502
Start Date
September 1 2008
Last Update
March 7 2014
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site 1
Graz, Austria
2
Boehringer Ingelheim Investigational Site 2
Linz, Austria
3
Boehringer Ingelheim Investigational Site 3
Salzburg, Austria
4
Boehringer Ingelheim Investigational Site 4
Vienna, Austria